POZEN Turns To Profit In Q4 - Quick Facts

(RTTNews) - POZEN Inc. (POZN), a pharmaceutical company committed to transforming medicine that transforms lives, posted fourth-quarter net income attributable to common stockholders of $7.0 million or $0.21 per share, compared to net loss of $2.2 million or $0.07 per share in the prior year period.

Operating expenses for the fourth quarter of 2014 totaled $3.1 million, as compared to $6.9 million for the comparable period in 2013. The decrease in operating expenses in the fourth quarter of 2014 was primarily a result of reduced staff, reduced non-cash compensation expense and lower YOSPRALA related costs.

Total revenue for the latest fourth-quarter rose to $9.89 million from $4.67 million in the comparable quarter last year.